Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05835388 · ClinicalTrials.gov registry record
The South Texas Aging Registry and Repository
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 149
- Enrollment target
NCT05835388: Completed study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT05835388 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05835388 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
This research registry and repository was designed because the investigators want to learn about how to improve the health and quality of life of older adults.
Primary Outcome
De-identified repository data and samples will be made available to outside investigators for future studies related to aging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2023-12-06 |
What the finished NCT05835388 record still lists
NCT05835388 is an observational study that tracks outcomes without assigning an intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05835388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05835388 about?
NCT05835388 is a clinical study titled "The South Texas Aging Registry and Repository". This research registry and repository was designed because the investigators want to learn about how to improve the health and quality of life of older adults.
What is the current status of trial NCT05835388?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2019-02-11. Estimated completion is 2023-12-06.
Who is sponsoring clinical trial NCT05835388?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI